Jun 8, 2020 — 3 min read
Lunit today announced that their AI solution for chest x-ray analysis is now being used and tested in more than 10 countries for COVID-19 management, providing assistance in chest x-ray interpretation during patient triage and monitoring.
The firm had released the AI solution in late March, providing the algorithm online to help healthcare providers manage COVID-19. Since then, the firm had deployed its software onsite in more than 10 locations throughout different countries, including Italy, France, Portugal, Brazil, Indonesia, Panama, South Korea, and etc.
“Together with our partners, we took a step further from providing the solution online, now actively deploying the AI on-site within the hospitals,” said Brandon Suh, CEO of Lunit. “The actual use of AI within COVID-19 management varies on the independent hospital systems and workflow, but generally the software provides assistance in the interpretation of chest x-ray images during triaging symptomatic patients and monitoring admitted patients with COVID-19.”
Lunit is in partnership with Vizyon, a French teleradiology firm that specializes in providing a platform for AI software by connecting the technology to hospitals. Vizyon is using Lunit AI in analyzing the images they receive from their clients.
“During patient triage, Lunit INSIGHT CXR developed for COVID-19 can accelerate the decision-making of patients with symptoms while awaiting PCR results,” says Dr. Pierre Durand of Vizyon. When the symptomatic patient shows up to a hospital, the patient is tested with both PCR and AI-assisted chest x-ray, with the latter providing an analysis result in less than 5 minutes.
“The doctor, upon reviewing the analysis made by AI, can promptly decide whether to send the patient back home or to the Emergency Hospital, depending on the severity. PCR results generally take six to 24 hours, risking a longer window of contamination while awaiting results, a longer gap of treatment, and a possible hospital overload,” Dr. Durand added.
Brazil was one of the early adopters of the solution, installed and tested at more than 11 hospitals including PreventSenior, one of the largest hospital networks in Brazil with 8 locations throughout the metropolitan region of Sao Paulo. Now having analyzed more than 30,000 chest x-ray images of COVID-19 cases in the last two months, a physician at PreventSenior says that “Lunit INSIGHT CXR seems to provide great help, especially for patient triage,” as the hospital is overflowing with patients while the number of radiologists remains limited.
In Italy, a country that saw large numbers of COVID-19 cases, Lunit AI is being used in Vimercate hospital, deployed through the company’s partnership with Fujifilm. The COVID-19 crisis has brought a need to improve workflow in the hospital, by easing the burden of reading a mass amount of exams. The hospital is based in Lombardia, Italy, and takes around 160,000 radiology exams in a year with 17 radiologists and 19 technicians.
AI findings are integrated into the Fujifilm Synapse platform which Vimercate hospital uses for reading radiologic images. According to the hospital, Lunit INSIGHT is used for every chest x-ray analysis, including emergency room patients with respiratory symptoms and patients with COVID-19. It is also used to examine a discharging patient with no symptoms, and to evaluate the feasibility of anesthesia prior to a surgical operation.
The original algorithm of Lunit INSIGHT CXR detects 10 findings from chest x-ray images including consolidation, nodule, pneumothorax, and more. It is CE marked and clinically available in Europe.
“Among the many hospitals we have been in touch with, many of them were experiencing frustrations from limited PCR tests and/or a lack of manpower and resources,” says Minhong Jang, Chief Business Officer at Lunit. “In hopes of sharing the burden, we are seeking more health facilities where we can provide assistance with advanced technology. We welcome you to learn more about our solution and reach out to better manage the current crisis."
Lunit wins Tumor Proliferation Assessment Challenge (TUPAC) 2016
Lunit to unveil data-driven imaging biomarker at RSNA 2016
Lunit to showcase AI-powered products at USCAP 2017
Lunit INSIGHT: The First-ever, Real-time Imaging AI Analytics on the Web
Lunit Returns to RSNA with Real-time Imaging Platform, Featuring Cloud-based A
Lunit Unveils “Lunit INSIGHT,” A New Real-time Imaging AI Platform on the Web at RSNA 2017
Lunit INSIGHT: Q&A with Brandon B. Suh, Chief Medical Officer at Lunit
Media Advisory: Lunit at RSNA 2018
Lunit Opens “Lunit INSIGHT for Mammography” for Public Access
Lunit Brings its Newest AI Solution for Mammography to RSNA 2018
Lunit Partners with Fujifilm and Salud Digna to Provide Medical AI Solution in Mexico
Lunit to Present Abstracts on AI-powered Precision Pathology at 2019 AACR Annual Meeting
Lunit to Showcase AI Solution for Breast Cancer at SBI 2019
Lunit to Present Findings on the Predictive Power of AI Biomarker for Lung Cancer Immunotherapy at ASCO 2019
Lunit Receives Korea MFDS Approval for its AI Solution for Breast Cancer, Lunit INSIGHT MMG
Lunit Gets Korea MFDS Approval for its AI Solution for Chest X-ray, Lunit INSIGHT CXR 2
Lunit at RSNA 2019
Lunit Announces its First CE Mark for AI-Powered Chest X-ray Analysis Software, Lunit INSIGHT CXR
Lunit AI software clinically installed in global sites—to be presented at RSNA 2019
AI-assisted Radiologists Can Detect More Breast Cancer with Reduced False-positive Recall
Lunit Releases Its AI Online to Support Healthcare Professionals Manage COVID-19
Lunit to Present Findings on the Predictive Power of AI-based Analysis of Immune Phenotype at ASCO 2020
Lunit INSIGHT MMG, an AI Solution for Breast Cancer Detection, Now CE Certified
Lunit Awarded as Technology Pioneer by World Economic Forum
Lunit at ECR 2020: Providing Virtual Exhibition and Online Presentations
Emergent Connect Partners with Lunit to Provide Cloud Based AI Solutions
AI Analysis Can Improve Lung Cancer Detection on Chest Radiographs
AI has Added Value in Insurance Underwriting Process, Recent Pilot Project Between Lunit and Cathay Financial Innovation Lab Reveals
RSNA 2020--Lunit Collaborates with Global Giants in Presenting its AI Solution at Virtual Booths of GE Healthcare, FujiFilm, and Sectra
AI Proves Its Value in Assistance for Emergency Cases-- With Higher Accuracy and Timely Reporting Time of Chest Radiographs
Lunit Expands Collaboration with GE Healthcare to Advance AI Adoption across Healthcare Industry
AI Can Offer Fast and Reliable Examination to Triage COVID-19 Patients-- A Multicenter Retrospective Study Reveals
Recent Studies Reveal High Performance of Lunit AI in Breast Cancer Detection
South Korean Medical AI Provider and PACS Leader Enters Indonesian Market, to Help COVID-19 Screening and Diagnosis
Will AI Identify Breast Cancer Better Than Radiologists in Actual Clinical Screening?
Clinical Application of Lunit AI For Chest Radiography and Mammography to Be Presented at AOCR 2021
A Multi-reader Study Finds Unnecessary CT Exams Can Be Reduced by 30% When Analyzing Chest Radiographs with AI
Fujifilm Introduces its AI-powered Product for Chest X-ray in Japan, in Collaboration with Lunit
Lunit Collaborates with Intel to Provide AI Solutions to CPU-Based Customers in Need of Effective X-ray Diagnosis
Lunit to Participate in RSNA 2021, Presenting its New AI Solutions for Digital Breast Tomosynthesis and Chest CT
RadLink, Singapore’s Leading Imaging Center, Adapts Lunit AI to Analyze Chest X-rays and Mammograms
Lunit Expands Team with Multiple Industry Leaders to Accelerate its Business Growth
Lunit Gets FDA Nod for AI-based Chest X-ray Triage Solution, Developed for Sorting of Emergency Cases
Lunit's AI Software for Breast Cancer Detection, Lunit INSIGHT MMG, Wins FDA Clearance
Research Backs Clinical Efficacy of Lunit's Radiology AI Products; Abstracts to be Presented at RSNA 2021
Lunit Named to the 2021 CB Insights Digital Health 150 -- List of Most Innovative Digital Health Startups
Lunit Obtains MDSAP Certificate, Granted Fast-Track Regulatory Process in Major Countries
Lunit to Showcase Chest and Breast Radiology AI in Arab Health 2022
Baheya Foundation, Egypt’s Premier Destination for Breast Cancer, Adopts Lunit AI to Enhance Early Screening
Medical AI Startup Lunit gets Preliminary Approval to go Public on KOSDAQ
Lunit to Present 11 Abstracts at the 2022 ASCO Annual Meeting
Lunit Files Registration Statement for Initial Public Offering
Lunit AI Solution for Radiology Receives Health Canada Nod for Commercial Use